Medtech Archives - Page 39 of 115 - Boston Life Sciences Times

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

December 16, 2025

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

December 13, 2025

Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option

December 12, 2025

THIS WEEK'S STORIES

Linus Health appoints Julie Wood, MD, MPH, FAAFP, as senior medical director for clinician engagement

December 15, 2025

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

December 11, 2025

Study Links Tumor Metabolism to Drug Binding Behavior in Live Cancer Cells

December 9, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

Hologic AI Mammography Technology Flags One-Third of Breast Cancer Cases Initially Read as Negative in Large Screening Study

Thermedical Treats First Patient in Pivotal Study Evaluating SERF Ablation for Life-Threatening Ventricular Tachycardia

Insulet Expands Omnipod U.S. Recycling Program Nationwide

Vektor Medical receives FDA 510(k) clearance expanding vMap’s non-invasive cardiac mapping capabilities

Owlet Launches TGA-Approved Dream Sock in Australia and New Zealand, Expanding Global Reach of Pediatric Health Monitoring

Most Read

Calluna Pharma Appoints Gijs van den Brink, MD, PhD, as Independent Director

Cosette Pharmaceuticals Launches First Generic Version of CIPRO HC Following FDA Approval

nChroma Bio Receives Clinical Trial Authorization to Launch First-in-Human Study of CRMA-1001 for Chronic Hepatitis B

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

EDITOR PICKS

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option

THIS WEEK'S STORIES

Linus Health appoints Julie Wood, MD, MPH, FAAFP, as senior medical director for clinician engagement

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

Study Links Tumor Metabolism to Drug Binding Behavior in Live Cancer Cells

POPULAR CATEGORY

ABOUT US

FOLLOW US